Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted in China to provide evidence for inclusion in applications to
competent authorities that the Compound Sodium Alginate Oral Suspension sachet is effective
in managing the symptoms of heartburn and acid regurgitation in patients with
gastro-esophageal reflux disease (GERD).